According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors

Update: 2021-08-10

Description

When we first launched our Salvagene COVID-19 Immunization Program in April 2020, our SARS-CoV-2 Task Force decided to incorporate testing of the interferons and their receptors, both analytically and more specifically epigenetically.

Comments

In Channel

Dr. Robert Hess : Long Covid After Vaccination

2022-03-2306:38

Dr. Robert Hess: Managing the Covid-19 aftermath: Detox of the spike- protein

2022-03-0910:51

Dr Robert Hess: Long Covid risk factors now identified

2022-02-1706:11

Dr Robert Hess: Best medication yet? Paxlovid a potential game changer

2022-01-2409:16

Dr Robert Hess: How do viruses – and more particularly SARS-CoV-2 – interfere with the p53 pathway?

2021-12-2210:11

Dr Robert Hess: What next for the SARS-CoV-2 pandemic?

2021-11-2412:51

Dr Robert Hess announces the flu season is just around the corner

2021-11-1009:13

Dr Robert Hess: new concepts such as antibody therapy and vaccination by inhalation against COVID-19 infection

2021-09-1707:22

Dr Robert Hess speaks about the FDA grants full approval to the Pfizer/BioNTech COVID-19 vaccine

2021-09-0604:53

Dr Robert Hess questions booster jab or next-generation vaccine?

2021-09-0204:37

According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors

2021-08-1019:29

Dr Robert Hess, the founder of Salvagene, about Covid-19 immunization possibilities.

2021-07-1929:07

00:00

According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors

#box-pro-ellipsis-176242627442650{-webkit-line-clamp:2;}According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors

According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors

Scott and Miriam Hiebert

According to Dr Robert Hess, there is In the center of the pandemic's interest: The interferons and their receptors